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Recently, the importance of FLT3L in driving PDC/IPCMysterious Origin of Plasmacytoid
development during hematopoiesis has been recog-Dendritic Cell Precursors nized (Brasel et al., 2000; Gilliet et al., 2002). However,
understanding the essential role of FLT3L in DC develop-
ment led to more recent studies revealing that FLT3
cells within either common lymphoid progenitors (CLP)
The origin of plasmacytoid dendritic cell precursors or common myeloid progenitors (CMP) could differenti-
(pDC) has been controversial. This manuscript shows ate into both myeloid DCs and pDCs in cultures and
that CLP and CMP both can give rise to pDCs. pDCs in vivo (D’Amico and Wu, 2003). In addition, studies in
derived from CMP express RAG gene products and mice deficient in IRF-8, a critical transcriptional factor
show IgHD-J rearrangement, suggesting that pDC for the myeloid cell lineage (Tamura and Ozato, 2002),
represent a unique lineage whose gene expression demonstrated that the generation of pDCs/IPCs, CD8
program shows substantial plasticity. DCs, epidermal DCs, and dermal DCs were all impaired
(Aliberti et al., 2003; Schiavoni et al., 2002, 2004; Tsuji-
mura et al., 2003). As a result of these seemingly diver-The innate and adaptive limbs of the immune system
gent findings, several different hypotheses have beenhave evolved a set of complex interactions to protect
proposed regarding the developmental origin of pDCs,us from invading microbial and viral pathogens. As the
including the existence of a common DC precursor inkey player bridging these two aspects of host defense,
blood that can give rise to all DC subsets (Del Hoyo etthe dendritic cell (DC) lineage has evolved distinct sub-
al., 2002), pDCs arising as a branch of the committedsets that are endowed with different properties and that
lymphoid lineage (Corcoran et al., 2003b; Grouard et al.,promote a variety of immune responses (Shortman and
1997), and lineage conversion (Comeau et al., 2002).Liu, 2002). Like other cell lineages within the immune
To determine the origin of pDCs more definitively,system, DCs are generated continuously through life
the Akashi group (Shigematsu et al., 2004 [this issueand diversified in an antigen-independent manner in
of Immunity]) directly tested the potential of myeloid-bone marrow. Originally, DCs were identified on the ba-
and lymphoid-committed progenitors, including CMP,sis of their morphology, phenotype, enzymatic activities,
GMPs, and CLPs, to give rise to pDCs. The results dem-and endocytic or phagocytic capacity (Steinman and
onstrated that pDC as well as conventional DCs couldCohn, 1973). The finding that DCs can be generated
be derived from all of these lineage-restricted progeni-from major histocompatibility complex (MHC) class II-
tors, but not from myeloid-erythroid progenitors (MEP)negative myeloid progenitors along with macrophages
or from pro-B cells, suggesting that pDCs have theand granulocytes suggested that DC are mainly myeloid
same origin as conventional DC subsets. Moreover, bothcells (Inaba et al., 1993), whereas the observation that
lymphoid and myeloid progenitor-derived pDCs pro-DCs can also arise from thymic T cell progenitors led
duced large amounts of type 1 IFN, expressed similarto the concept of a distinct lineage of lymphoid-derived
patterns of DC-related genes, and contained IgH D-JDCs (Ardavin et al., 1993).
rearrangements. These results clearly showed that pDCThe discovery of plasmacytoid dendritic cell precur-
progeny can, like other DC subsets, arise during hema-sors (pDC) or type I interferon-producing cells (IPCs)
topoiesis from progenitors of distinct restricted lin-has increased the recognized complexity of DC subsets
eage potential.(Grouard et al., 1997). PDCs possess a distinct plasma
The authors also explored the issue of why myeloid-cell-like morphology and secrete prodigious amounts
derived pDCs possess D-J rearranged IgH gene seg-of type I interferon as professional IPC upon viral expo-
ments, molecular events that are undetectable in CMPsure or stimulation by unmethylated CpG DNA due to
or GMP. They approached the question by examiningtheir selective expression of Toll-like receptors (TLR) 7
the RAG locus expression pattern in the progenitors asand TLR9 (Kadowaki et al., 2000). Activated pDCs can
well as in lymphoid- and myeloid-derived pDCs isolatedthen rapidly differentiate into mature DCs, which are
from RAG1-EGFP knockin mice. They showed that RAGcapable of activating T cells. While these studies dem-
expression and D-J IgH rearrangements were not de-onstrate that pDCs represent a functionally distinct cell
tectable in CMPs but were present in CMP-derivedlineage with roles in both innate and adaptive immune
pDCs. This surprising finding allowed the authors toresponses, there remains substantial uncertainty about
suggest that the expression of RAG and D-J IgH rear-the identity of the cells from which they are derived
rangements in CMP-derived pDCs does not necessarilyand about the developmental pathway they follow. The
reflect their lineage origin, but results instead from thenotion that pDCs are of lymphoid origin was supported
“ectopic” low-level expression of RAG genes duringby findings that the gene transcripts of pre-T cell recep-
CMP differentiation into pDCs. Moreover, they also ob-tor  (pT), 5, Spi-B, as well as IgH D-J gene rearrange-
served that human pT transcription is upregulated afterments could be found in pDCs, but not by myeloid DCs
progenitors differentiate into pDCs irrespective of their(Corcoran et al., 2003a). In addition, overexpression of
lineal origin. Therefore, the expression of rearrangedthe dominant-negative transcription factors Id2 or Id3
D-J IgH, RAG, and human pT genes in pDCs does notblock the development of PDC/IPC, T, and B cells, but
not the development of myeloid DCs (Spits et al., 2000). appear to reflect their derivation from CLP as frequently
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The different Ly49 gene family members appear to beBidirectional Promoters Regulate
regulated largely independently, such that the frequencythe Monoallelically Expressed of cells expressing any given pair (or larger group) is
approximated by multiplying the respective frequenciesLy49 NK Receptors
of expression of the individual genes; this pattern of
expression has been termed the product rule. Another
important observation about the regulation of these
Members of the Ly49 gene family of natural killer (NK) genes is that they are subject to random monoallelic
cell receptors in mice are expressed in seemingly expression (Held et al., 1995), similar to the regulation
stochastic combinations such that each NK cell ex- of odorant receptor genes (Chess et al., 1994) and in-
presses a handful of family members. A transcriptional terleukin genes (Bix and Locksley, 1998; Hollander et
switch appears to establish this interesting pattern al., 1998; Rhoades et al., 2000). Random monoallelic
of expression. expression is of particular interest because it indicates
that identical sequences (the two alleles of a given gene)
present in the same nucleus may be regulated indepen-The purpose of natural killer (NK) cells is to attack cells
dently.displaying abnormalities including infection or transfor-
Two recent papers have recently examined the ex-mation. The decision as to whether to attack a potential
pression of Ly49 genes in vivo and in vitro. Tanamachi ettarget cell is made based on the balance of activation of
al. (2004) used transgenes to recapitulate the variegatedstimulatory and inhibitory receptors. Individual inhibitory
expression of Ly49a: of eight Ly49a transgenic founderreceptors are specific for subsets of the highly polymor-
lines, six showed variegated expression similar to thephic MHC class 1 molecules (Raulet et al., 2001).
endogenous Ly49 genes. A striking aspect of theseThe Ly49 family in mice is a family of more than 10
transgenic analyses is that they reveal independent reg-distinct NK cell activating and inhibitory receptors. In
ulation of the transgene and the endogenous Ly49ahumans, the functions of the Ly49 family are subserved
alleles. Normally, a properly functioning transgene isby a distinct family, the KIR genes, which have an immu-
expressed in the exact same cells as express the endog-noglobulin-like structure instead of the C-type lectin
enous alleles of that gene. The normal situation reflectsstructure of the Ly49 genes. The expression of a seem-
the fact that the transgene is exposed to the same tran-ingly randomly chosen handful of the Ly49 family mem-
bers serves to define each NK cell (Raulet et al., 2001). scription factor milieu as the endogenous alleles. Given
